인쇄하기
취소

KFDA Denies Its Upcoming Decision to Disapprove on ‘Bacchus-S’

Published: 2004-12-27 06:57:00
Updated: 2004-12-27 06:57:00
Amid the continuing decision delays by the Korea Food and Drug Administration (KFDA) on the possible use of a trademark ‘Bacchus-S’, a quasi-medicine, requested by Dong-A Pharmaceutical, the KFDA made an official statement in response to a recent news release by a domestic press, where it suggested the KFDA’s upcoming decision to disapprove the request.

YonhapNews reported on December 22nd t...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.